查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
北美临床参考实验室市场预测至 2031 年 - 区域分析 - 按服务提供者（医院、独立和诊所）和应用（实验室医学、临床试验等）
市场调查报告书
商品编码
1597166

北美临床参考实验室市场预测至 2031 年 - 区域分析 - 按服务提供者（医院、独立和诊所）和应用（实验室医学、临床试验等）

North America Clinical Reference Laboratory Market Forecast to 2031 - Regional Analysis - by Service Provider (Hospital-Based, Standalone, and Clinic-Based) and Application (Laboratory Medicine, Clinical Trials, and Others)
出版日期: | 出版商: The Insight Partners | 英文 103 Pages | 订单完成后即时交付

价格

2023年北美临床参考实验室市值为175.7005亿美元，预计到2031年将达到291.0442亿美元；预计2023年至2031年复合年增长率为6.5%。

慢性病和传染病的上升推动了北美临床参考实验室市场

慢性病盛行率的不断上升以及各种传染病的出现和爆发刺激了对新治疗方案和更新治疗类别的需求，并在现有治疗类别中产生了对更好治疗方案的需求。根据世界卫生组织2023年9月发布的资料，包括心臟病、癌症、中风、糖尿病和慢性肺病在内的非传染性疾病（NCD）每年导致4,100万人死亡。据联合健康基金会称，到 2022 年，超过 2900 万美国成年人报告患有三种或以上慢性病。临床参考实验室在现代医疗保健中发挥着重要作用。参考实验室为需要专门实验室检测设备和专业知识的传染病（例如猪流感、甲型和B型肝炎）提供快速诊断服务。 。在 COVID-19 大流行期间，很明显，医学参考实验室对于快速测试、建立新技术、生成和分析资料以及作为知识中心至关重要。参考实验室不仅仅是大容量测试设施；它们是专业知识和资料的中心。因此，传染病和慢性病的盛行率上升正在推动临床参考实验室市场的成长。

北美临床参考实验室市场概况

美国是领先的临床研究目的地之一。近一半的临床试验是在美国进行的。此外，由于审批时间短、监管框架有利以及医疗基础设施完善，大多数製药研究公司选择在美国进行临床试验。此外，美国临床试验产生的资料已被全球接受。根据世界卫生组织（WHO）2021年报告，美国登记的临床试验数量最多（157,618项）。

下表显示了在美国註册的临床试验数量、招募的患者总数以及美国在全球给定参数中所占的百分比。

2023年

註册临床试验研究

研究中招募的患者

我们

139,632（全球研究的 31%）

20,680 名（占全球员工总数的 32%）

资料来源：ClinicalTrial.gov 报告

透过併购扩大公司准入进一步推动了美国临床参考实验室市场的成长。例如，2020年12月，美国私人临床检测实验室临床参考实验室（CRL）收购了领先的综合筛检工具和解决方案供应商Confirm BioSciences。确认将继续以目前的名称作为子公司。此次收购扩大了Confirm获得实验室测试服务和研发能力的机会。 NCEZID 实验室、梅奥诊所实验室和 CRL 是领先的临床试验参考实验室之一。美国临床试验数量的不断增加有利于该国临床参考实验室市场的成长。

北美临床参考实验室市场收入及 2031 年预测（百万美元）

北美临床参考实验室市场细分

北美临床参考实验室市场按服务提供者、应用程式和国家分类。

根据服务供应商，北美临床参考实验室市场分为医院型、独立型和诊所型。 2023 年，医院细分市场占据最大的市场份额。

从应用来看，北美临床参考实验室市场分为检验医学、临床试验等。 2023 年，检验医学领域占据最大的市场份额。

依国家/地区划分，北美临床参考实验室市场分为美国、加拿大和墨西哥。 2023 年，美国主导北美临床参考实验室市占率。

Sonic Healthcare Ltd、Laboratory Corp of America Holdings、Quest Diagnostics Inc、ARUP Laboratories Inc、Clinical Reference Laboratory Inc、SYNLAB International GmbH、Myraid Genetics Inc、Boca Biolistics LLC 和 TOPLAB 是北美临床参考领域的一些领先公司实验室市场。

目录

第 1 章：简介

第 2 章：执行摘要

  • 北美主要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：北美临床参考实验室市场 - 主要市场动态

  • 市场驱动因素
    • 慢性病和传染病的盛行率上升
    • 临床试验数量不断增加
  • 市场限制
    • 与规范架构和采用持续技术发展相关的复杂性
  • 市场机会
    • 与参考实验室的策略倡议
  • 未来趋势
    • 人工智慧在临床参考实验室的应用
  • 驱动因素和限制的影响：

第 5 章：临床参考实验室市场 - 北美分析

  • 临床参考实验室市场收入，2021-2031
  • 临床参考市场预测与分析

第 6 章：北美临床参考实验室市场分析 - 按服务提供者

  • 概述
  • 以医院为基础
  • 独立式
  • 基于临床

第 7 章：北美临床参考实验室市场分析 - 按应用

  • 概述
  • 检验医学
  • 临床试验
  • 其他的

第 8 章：北美临床参考实验室市场 - 国家分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥

第 9 章：临床参考实验室市场-产业格局

  • 概述
  • 临床参考实验室市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 10 章：公司简介

  • Sonic Healthcare Ltd
  • Laboratory Corp of America Holdings
  • Quest Diagnostics Inc
  • ARUP Laboratories Inc
  • Clinical Reference Laboratory Inc
  • SYNLAB International GmbH
  • Myraid Genetics Inc
  • Boca Biolistics LLC
  • TOPLAB

第 11 章：附录

Product Code: BMIRE00030831

The North America clinical reference laboratory market was valued at US$ 17,570.05 million in 2023 and is expected to reach US$ 29,104.42 million by 2031; it is estimated to register a CAGR of 6.5% from 2023 to 2031.

Rising Prevalence of Chronic and Infectious Diseases Fuels North America Clinical Reference Laboratory Market

The increasing prevalence of chronic diseases and the emergence and outbreak of various infectious diseases have fueled the demand for novel treatment options and newer therapeutic categories and created the need for better treatment options in existing therapeutic categories. According to the WHO data released in September 2023, noncommunicable diseases (NCDs), including heart disease, cancer, stroke, diabetes, and chronic lung disease, kill 41 million people each year. According to the United Health Foundation, more than 29 million US adults reported having three or more chronic conditions in 2022. Accurate diagnostics are critical for identifying disease biomarkers and detecting organisms, particularly in cancer and tuberculosis. Clinical reference laboratories play an important role in modern healthcare. The reference laboratories provide services for the quick diagnosis of infectious diseases that require specialized laboratory testing equipment and expertise, such as swine flu, hepatitis A and B. These laboratories also offer low-cost diagnostic testing for common chronic conditions such as cancer, diabetes, and cardiovascular disease. During the COVID-19 pandemic, it became evident that medical reference labs are critical for rapid testing, establishing novel techniques, generating and analyzing data, and serving as knowledge hubs. Reference labs are more than just high-volume testing facilities; they are the hubs of expertise and data. Thus, the rising prevalence of infectious and chronic diseases is driving the growth of the clinical reference laboratory market.

North America Clinical Reference Laboratory Market Overview

The US is one of the leading clinical research destinations. Nearly half of the total clinical trials are performed in the US. Additionally, most pharmaceutical research companies choose to perform clinical trials in the US owing to fast approval timelines, a favorable regulatory framework, and established medical infrastructure. Moreover, data generated for clinical trials in the US is accepted globally. According to the World Health Organization (WHO) report in 2021, the US registered the highest number of clinical trials (157,618).

The expanding access of companies through mergers and acquisitions further boosts the growth of the clinical reference laboratory market in the US. For instance, in December 2020, Clinical Reference Laboratory (CRL)-a privately held clinical testing laboratory in the US-acquired Confirm BioSciences, a leading provider of comprehensive screening tools and solutions. Confirm will continue as a subsidiary under its current name. The acquisition expands Confirm's access to lab testing services and R&D capabilities. NCEZID laboratories, Mayo Clinic Laboratories, and CRL are among the leading reference laboratories for clinical trials. The growing number of clinical trials in the US favors the growth of the clinical reference laboratory market in the country.

North America Clinical Reference Laboratory Market Segmentation

The North America clinical reference laboratory market is categorized into service provider, application, and country.

Based on service provider, the North America clinical reference laboratory market is segmented into hospital-based, standalone, and clinic-based. The hospital-based segment held the largest market share in 2023.

In terms of application, the North America clinical reference laboratory market is categorized into laboratory medicine, clinical trials, and others. The laboratory medicine segment held the largest market share in 2023.

By country, the North America clinical reference laboratory market is segmented into the US, Canada, and Mexico. The US dominated the North America clinical reference laboratory market share in 2023.

Sonic Healthcare Ltd, Laboratory Corp of America Holdings, Quest Diagnostics Inc, ARUP Laboratories Inc, Clinical Reference Laboratory Inc, SYNLAB International GmbH, Myraid Genetics Inc, Boca Biolistics LLC, and TOPLAB are some of the leading companies operating in the North America clinical reference laboratory market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 North America Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Clinical Reference Laboratory Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Prevalence of Chronic and Infectious Diseases
    • 4.1.2 Increasing Number of Clinical Trials
  • 4.2 Market Restraints
    • 4.2.1 Complications Related to Regulatory Framework and Adoption of Continuous Technological Developments
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives with Reference Laboratories
  • 4.4 Future Trends
    • 4.4.1 Use of Artificial Intelligence in Clinical Reference Laboratories
  • 4.5 Impact of Drivers and Restraints:

5. Clinical Reference Laboratory Market - North America Analysis

  • 5.1 Clinical Reference Laboratory Market Revenue (US$ Million), 2021-2031
  • 5.2 Clinical Reference Market Forecast and Analysis

6. North America Clinical Reference Laboratory Market Analysis - by Service Provider

  • 6.1 Overview
  • 6.2 Hospital-Based
    • 6.2.1 Overview
    • 6.2.2 Hospital-Based: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Standalone
    • 6.3.1 Overview
    • 6.3.2 Standalone: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.4 Clinical Based
    • 6.4.1 Overview
    • 6.4.2 Clinical-Based: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)

7. North America Clinical Reference Laboratory Market Analysis - by Application

  • 7.1 Overview
  • 7.2 Laboratory Medicine
    • 7.2.1 Overview
    • 7.2.2 Laboratory Medicine: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Clinical Trials
    • 7.3.1 Overview
    • 7.3.2 Clinical Trials: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Clinical Reference Laboratory Market - Country Analysis

  • 8.1 North America
    • 8.1.1 North America: Clinical Reference Laboratory Market Breakdown, by Key Country, 2023 and 2031 (%)
      • 8.1.1.1 US: Clinical Reference Laboratory Market - Overview
      • 8.1.1.2 US: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.2.1 US: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million), by Service Provider
        • 8.1.1.2.2 US: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
      • 8.1.1.3 Canada: Clinical Reference Laboratory Market - Overview
      • 8.1.1.4 Canada: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.4.1 Canada: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
        • 8.1.1.4.2 Canada: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
      • 8.1.1.5 Mexico: Clinical Reference Laboratory Market - Overview
      • 8.1.1.6 Mexico: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.6.1 Mexico: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
        • 8.1.1.6.2 Mexico: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application

9. Clinical Reference Laboratory Market-Industry Landscape

  • 9.1 Overview
  • 9.2 Growth Strategies in the Clinical Reference Laboratory Market
  • 9.3 Inorganic Growth Strategies
    • 9.3.1 Overview
  • 9.4 Organic Growth Strategies
    • 9.4.1 Overview

10. Company Profiles

  • 10.1 Sonic Healthcare Ltd
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Laboratory Corp of America Holdings
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Quest Diagnostics Inc
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 ARUP Laboratories Inc
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Clinical Reference Laboratory Inc
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 SYNLAB International GmbH
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 Myraid Genetics Inc
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 Boca Biolistics LLC
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments
  • 10.9 TOPLAB
    • 10.9.1 Key Facts
    • 10.9.2 Business Description
    • 10.9.3 Products and Services
    • 10.9.4 Financial Overview
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Developments

11. Appendix

  • 11.1 About The Insight Partners
  • 11.2 Glossary of Terms

List Of Tables

  • Table 1. North America Clinical Reference Laboratory Market Segmentation
  • Table 2. Clinical Reference Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. US: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
  • Table 4. US: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 5. Canada: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
  • Table 6. Canada: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 7. Mexico: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
  • Table 8. Mexico: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 9. Recent Inorganic Growth Strategies in the Clinical Reference Laboratory Market
  • Table 10. Recent Organic Growth Strategies in the Clinical Reference Laboratory Market
  • Table 11. Glossary of Terms

List Of Figures

  • Figure 1. North America Clinical Reference Laboratory Market Segmentation, by Country
  • Figure 2. Clinical Reference Laboratory Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Clinical Reference Laboratory Market Revenue (US$ Million), 2021-2031
  • Figure 5. Clinical Reference Laboratory Market Share (%) - by Service Provider (2023 and 2031)
  • Figure 6. Hospital-Based: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Standalone: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Clinical-Based: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Clinical Reference Laboratory Market Share (%) - by Application (2023 and 2031)
  • Figure 10. Laboratory Medicine: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Clinical Trials: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Others: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. North America: Clinical Reference Laboratory Market, by Key Country - Revenue (2023) (US$ Million)
  • Figure 14. North America: Clinical Reference Laboratory Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 15. US: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Canada: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Mexico: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Growth Strategies in the Clinical Reference Laboratory Market